Plasma Protein Therapeutics Market (Product - Albumins, Immunoglobulins, C1-Esterase Inhibitors, Hyperimmune Globulins, and Coagulation Factors; Application - Idiopathic Thrombocytopenic Purpura, Hereditary Angioedema, Secondary Immunodeficiency, Primary Immunodeficiency Disorder, and Other Indications): Global Industry Analysis, Trends, Size, Share and Forecasts to 2024. The global plasma protein therapeutics market is projected to grow at a CAGR of 6.1% over the forecast period of 2018-2024.
Pune, India -- (SBWIRE) -- 04/16/2019 -- The latest report on Plasma Protein Therapeutics Market by Infinium Global Research gives complete coverage of the Plasma Protein Therapeutics Market by product (albumins, immunoglobulins, c1-esterase inhibitors, hyperimmune globulins, coagulation factors), application (idiopathic, hereditary angioedema, secondary, primary immunodeficiency disorder, other indications) in terms of key trends, market size, forecast and CAGR growth over the period of 2018 to 2024. In addition, the study covers deep dive into key product and applications trends in the regional markets of Plasma Protein Therapeutics such as North America, Europe, Asia-Pacific and Latin America over the short run and long run. The global plasma protein therapeutics market is projected to grow at a CAGR of 6.1% over the forecast period of 2018-2024.
For More Details Get FREE Sample Pages of this Premium Global Report@ https://www.infiniumglobalresearch.com/reports/sample-request/3398
Plasma Protein Therapeutics Market: Industry Insights
Plasma proteins which are also termed as blood proteins serve different functions like transport of lipids, hormones, vitamins, and minerals throughout the body and functioning of the immune system. Among all, three major proteins prominently present in the plasma are albumin, globulin, and fibrogen. Albumin, a major protein compromising 55% in plasma, serves the function of maintaining osmotic pressure of plasma and assists as a carrier in the transport of lipids and steroid hormone. Globulins are a second large part of plasma around 38%, carries ions, hormones, and lipids which assist in immune functions. Fibrinogen is an important protein compromising 7% of blood proteins helps in blood clotting process by converting fibrinogen into insoluble fibrin. Owing to large demand in medicinal use plasma proteins market expects high growth in the forecast period.
Plasma Protein Therapeutics Market: Drivers and Restraints
Increasing genetic and chronic diseases like plasma cell dyscrasias, protein-losing disorders, liver diseases, plasma cell dyscrasias, humoral immune deficiencies, autoimmune diseases, genetic deficiency states have triggered plasma protein therapeutic demand globally. Strong demand for albumin in the Asia Pacific and higher volume of immunoglobulin usage in developed countries are projected to drive the market over the forecast period. Furthermore, increasing R & D activities and high demand for advanced therapeutic options are expected to trigger the market growth in the forecast period. However stringent regulatory policies and complexities for manufacturing plasma protein drugs and reimbursement issues can restraint the growth of the market.
More Insights on this report, Speak to Our Analyst: https://www.infiniumglobalresearch.com/reports/enquiry/3398
Plasma Protein Therapeutics Market: Segmentation
Global Plasma Protein Therapeutics Market segmented by product and application, product segment further sub-segmented into Albumins, Immunoglobulins, C1-esterase Inhibitors, Hyperimmune, and Coagulation Factors. Immunoglobulins followed albumins hold up a maximum share of the market due to their increasing importance in the therapeutic market. By application, the section is categorized as Hereditary Angioedema, Primary Immunodeficiency Disorder, Idiopathic Thrombocytopenic Purpura, Secondary Immunodeficiency and others. Out of these plasma protein therapeutics is widely used in the treatment of primary immunodeficiency disorder (PID) and expected to grow at high CAGR in the forecast period.
Plasma Protein Therapeutics Market: Regional Insight
On the basis of geographical region, the plasma protein market is segmented in the regions of North America, Europe, Asia-Pacific and rest of the world (RoW). North America expected to dominate the market followed by Europe this is because of the increasing use of protein therapeutics, swelling demand for immunoglobulin (IG). Presence of a large patient base and the presence of a large number of plasma protein products manufacturers are the key factors for the growth of these regions. In the Asia Pacific, China is the major exporter of albumin across the world owing to increased adoption of novel therapeutics and rising disease prevalence are some of the factors contributing to the regional growth.
Browse Complete Global Report and Detailed TOC: https://www.infiniumglobalresearch.com/healthcare-medical-devices/global-plasma-protein-therapeutics-market
Plasma Protein Therapeutics Market: Competitive Analysis
Some of the major players in global plasma protein therapeutic market are the Shire, Octapharma USA, Inc., Grifols, S.A., China Biologic Products Holdings, Inc., CSL Behring, Biotest AG, Baxter, Chengdu Institute of Biology (CIB) and others.
Reasons to Buy this Report:
- Comprehensive analysis of global as well as regional markets of the Plasma Protein Therapeutics.
- Complete coverage of all the product type and applications segments to analyze the trends, developments, and forecast of market size up to 2024.
- Comprehensive analysis of the companies operating in this market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and the latest developments of the company.
- Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.